Further, Kaplan–Meier survival analysis indicated that patients with PAAD or SKCM having high expression of SAE1 had a significantly shorter OS time compared with corresponding patients with low SAE1 expression (Figure 4b and c). The gene discussed is SAE1; the disease is pancreatic adenocarcinoma.